Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Novo Nordisk ( (NVO) ) has risen by 8.94%. Read on to learn why. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data and powerful investing...
The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back. Is there a more popular health trend right no...
The U.S. Food and Drug Administration has approved a weight-loss pill from Novo Nordisk (NVO) that could speed up how appetite-suppressing drugs reach the mass...
Analyst ratings
55%
of 33 ratingsMore NVO News
Novo Nordisk (NYSE:NVO) has been on a choppy ride lately, with the stock rebounding over the past month after a weaker stretch in the past 3 months and year to...
Mixed options sentiment in Novo Nordisk (NVO), with shares up 92c, or 1.79%, near $52.53. Options volume running well above average with 139k contracts traded a...
Below is Validea's guru fundamental report for NOVO NORDISK A/S (ADR) (NVO). Of the 22 guru strategies we follow, NVO rates highest using our Patient Investor m...
On Tuesday, the U.S. Food and Drug Administration (FDA) approved Novo Nordisk A/S' (NYSE:NVO) Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess b...
Novo Nordisk (NVO) announced an update on their ongoing clinical study. Claim 70% Off TipRanks This Holiday Season Study Overview: Novo Nordisk is running a P...
Shares of Novo Nordisk A/S ( NVO ) climbed 7.3% after the U.S. FDA approved its drug GLP-1 pill for the treatment of overweight or obesity. NVO Huntington Inga...
U.S.-based Eli Lilly & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are vying to capture a large portion of India’s rapidly growing obesity drug market. L...